B. ÇELİK Et Al. , "CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients," BIOMEDICAL REPORTS , vol.5, no.2, pp.259-263, 2016
ÇELİK, B. Et Al. 2016. CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. BIOMEDICAL REPORTS , vol.5, no.2 , 259-263.
ÇELİK, B., Yalcin, A. D., Genc, G. E., Bulut, T., Genc, S. K., & GÜMÜŞLÜ, S., (2016). CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. BIOMEDICAL REPORTS , vol.5, no.2, 259-263.
ÇELİK, BETÜL Et Al. "CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients," BIOMEDICAL REPORTS , vol.5, no.2, 259-263, 2016
ÇELİK, BETÜL Et Al. "CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients." BIOMEDICAL REPORTS , vol.5, no.2, pp.259-263, 2016
ÇELİK, B. Et Al. (2016) . "CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients." BIOMEDICAL REPORTS , vol.5, no.2, pp.259-263.
@article{article, author={BETÜL ÇELİK Et Al. }, title={CXCL8, IL-1 and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients}, journal={BIOMEDICAL REPORTS}, year=2016, pages={259-263} }